Quintiles launches new site start-up model

Monday, June 6, 2016

Quintiles, the world’s largest provider of biopharmaceutical services, has introduced a new patient enrollment offering designed to accelerate study startup and reduce costs for oncology clinical trials by opening investigative sites for studies only after they have identified a qualified patient.

[Read More]

Realities of Precision Medicine

Monday, February 15, 2016

As biopharmaceutical companies in­crease R&D investment in precision medicine, a trend that is expected to rise by one-third in the next five years, clini­cal research professionals will need to imple­ment operating practices and processes that can meet the complex demands of an indi­vidualized approach to drug development.

[Read More]